Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Therefore benserazide inhibits melatonin synthesis in the rodent but not in humans with the conventional doses used in the treatment of Parkinson's disease.”
Journal of neurology, neurosurgery, and psychiatry • 1991 | View Paper
“Therefore benserazide inhibits melatonin synthesis in the rodent but not in humans with the conventional doses used in the treatment of Parkinson's disease.”
“1 Low doses (50 and 80 mg/kg) of benserazide (Ro4‐4602), an aromatic amino acid decarboxylase inhibitor, markedly reduced 5‐hydroxytryptamine and melatonin in the rat pineal gland without affecting hypothalamic 5‐hydroxytryptamine.”